Warning over Aspirin link to increased risk of AMD (Added 20/02/13 )

A leading sight loss charity is warning patients with heart disease not to stop taking prescribed Aspirin even though a new study has linked it with a serious eye condition.

A new study suggests that Aspirin may increase the risk of developing wet age-related macular degeneration (wet AMD). However the Macular Society says that, for patients at risk of heart attacks, the dangers of stopping or not taking aspirin are much higher.

The study of 2389 participants in Australia was conducted by Dr Gerald Liew and colleagues. They monitored people over a 15 year period, finding a 2.5 fold greater risk of incident of AMD with regular low-dose aspirin use.

Age-related macular degeneration affects the central vision and is the most common cause of sight loss in the UK. More people are affected as our society ages.

Helen Jackman, Chief Executive of the Macular Society said: “We understand that patients will be concerned and they should discuss the risks with their doctors. Specialists we’ve consulted say that the evidence of a link between Aspirin and wet AMD is accumulating but it is not overwhelming. For patients with cardio-vascular disease who are taking Aspirin, the risk of heart attack is higher than the risk of developing wet AMD. In addition, there are treatments for wet AMD as long as it is diagnosed in time.

“However, patients with wet AMD in one eye should have their other eye carefully monitored so that any sign of wet AMD can be found quickly.

“We urge patients not to stop taking prescribed Aspirin without speaking to their doctors.”

For information, advice or support concerning macular disease, contact the Macular Society’s Helpline on 0300 3030 111 or emailhelp@macularsociety.org